Acute urticaria associated with paroxetine

Paroxetine is a well-tolerated drug used in the treatment of many psychiatric disorders. In this case report, we present a 31-year old female patient with major depression who developed acute urticaria during paroxetine therapy. Our patient’s laboratory examinations were normal and she had no history of urticaria or other skin reactions. She also had no family history of urticaria or other skin reactions. Dermatological reactions with paroxetine are rarely seen. Most of them are eczematous and benign lesions. As in our case, urticaria is a rare dermatologic reaction with paroxetine.

Paroksetin ile ilişkili akut ürtiker

Paroksetin, birçok psikiyatrik bozukluğun tedavisinde kullanılan ve iyi tolere edilen bir ilaçtır. Bu yazıda paroksetin kullanımı sırasında akut ürtiker gelişen majör depresyonlu 31 yaşında bir kadın hasta sunulmuştur. Hastamızın laboratuvar tetkikleri normaldi. Özgeçmişinde ve soygeçmişinde ürtiker veya diğer cilt reaksiyonları öyküsü yoktu. Paroksetin ile dermatolojik reaksiyonlar nadiren görülür. Çoğu egzematöz ve iyi huylu lezyonlardır. Bizim olgumuzda olduğu gibi, ürtiker paroksetin ile nadir görülen bir dermatolojik reaksiyondur.

___

1. Taylor DM, Barnes TR, Young AH. The Maudsley Prescribing Guidelines in Psychiatry. Thirteenth ed., London: Wiley Blackwell, 2018.

2. Krasowska D, Szymanek M, Schwartz RA, Myslinski W. Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors. J Am Acad Dermatol 2007; 56(5):848-853.

3. Spigset O. Adverse reactions of selective serotonin reuptake inhibitors. Drug Saf 1999; 20(3): 277-287.

4. Carr TF, Saltoun CA. Urticaria and angioedema. JA Bellanti (Ed.), Allergy and Asthma Proceedings, Chicago: Ocean Side Publications, 2012, pp.70-72.

5. Akpinar F, Dervis E. Drug eruptions: An 8-year study including 106 inpatients at a dermatology clinic in Turkey. Ind J Dermatol 2012; 57(3):194- 198.

6. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, fifth ed. Arlington, VA: American Psychiatric Association, 2013.

7. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30(2):239-245.

8. Mera MTS, Perez BV, Fernandez RO, Iglesias JFF. Hypersensitivity to paroxetine. Allergol Immunopathol 2006; 34(3):125-126.

9. Beauquier B, Fahs H. Secondary dermatologic effects of serotonin reuptake inhibitor antidepressants: hypothesis of cross-reacting allergy. A propos of 2 cases. Encephale 1998; 24(1):62-64.

10. Mameli, C, Tadini G, Cattaneo D, Cerini C, Zuccotti GV. Acute generalized exanthematous pustulosis induced by paroxetine in an adolescent girl. Acta Derm Venereol 2013; 93(6):733-734.

11. Margolese HC, Chouınard G, Beauclair L, Rubino M. Cutaneous vasculitis induced by paroxetine. Am J Psychiatry 2001; 158(3):497-497.

12. Ay R. Urticarial lesions associated with the use of paroxetine: a case report. Psychiatry Clin Psychopharmacol 2018; 28(3):352-354.

13. Mithani H, Hurwitz TA. Paroxetine-induced angioedema and tongue swelling. J Clin Psychiatry 1996; 57(10):486-486.

14. Cederberg J, Knight S, Svenson S, Melhus H. Itch and skin rash from chocolate during fluoxetine and sertraline treatment: case report. BMC Psychiatry 2004; 4(1):36.

15. Hausmann O, Schnyder B, Pichler WJ. Drug hypersensitivity reactions involving skin. Handb Exp Pharmacol 2010; 196:29-55.